Aquired immune hemolytic anemias;Erworbene immunhämolytische anämien

Therapeutische Umschau

Volumn 61, Issue 2, 2004, Pages 178-186

  Salama, A ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIRHEUMATIC AGENT; AUTOANTIBODY; AZATHIOPRINE; CEPHALOSPORIN DERIVATIVE; COLD AGGLUTININ; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DANAZOL; DEXAMETHASONE; DICLOFENAC; DOPAMINE; HEPARIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; METHYLPREDNISOLONE; PREDNISOLONE; RECOMBINANT ERYTHROPOIETIN; RITUXIMAB; SODIUM CARBONATE; TUBERCULOSTATIC AGENT;

ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNITY; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; COMPLEMENT ACTIVATION; CORTICOSTEROID THERAPY; DISEASE CLASSIFICATION; DRUG INDUCED DISEASE; ERYTHROCYTE CONCENTRATE; HEMOGLOBINURIA; HEMOLYSIS; HUMAN; IMMUNOADSORPTION; NEWBORN HEMOLYTIC DISEASE; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA;

EID: 1342346772     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.61.2.178     Document Type: Article

References (31)

1. Salama A, Heymann G. Nachweis von erythrozytären Antigenen und Antikörpern. Transfusionsmedizin 3. Auflage 2003; im Druck.
2. Dacie JV. Autoimmune hemolytic anemia. Arch Intern Med 1975; 135: 1293-1300.
3. Pirofsky B. Clinical aspects of autoimmune hemolytic anemia. Semin Hematol 1976; 13: 251-65.
4. Salama A, Ahrens N, Kiesewetter H. Serological and Clinical Aspects of Autoimmune Hemolytic Anemias. Infus Ther Transfus Med 2002; 29: 206-17.
5. Bussel JB, Cunningham-Rundles C, Abraham C. Intravenous treatment of autoimmune hemolytic anemia with very high dose gammaglobulin. Vox Sang 1986; 51: 264-9.
6. Salama A, Mahn I, Neuzner J, and al. e. IgG therapy in autoimmune haemolytic anaemia of warm type. Blut 1983; 48: 391.
7. Gehrs BC, Friedberg RC. Autoimmune Hemolytic Anemia. Am J Hematol 2002; 69: 258-71.
8. Salama A, Bhakdi S, Mueller-Eckhardt C, Kayser W. Deposition of the terminal C5b-9 complement complex on erythrocytes by human red cell autoantibodies. Br J Haematol 1983; 55: 161-9.
9. Roelcke D. Cold agglutination. Transfus Med Rev 1989; 3: 140-66.
10. Habibi B, Homberg JC, Schaison G, Salmon C. Autoimmune hemolytic anemia in children. A review of 80 cases. Am J Med 1974; 56: 61-9.
11. Zuelzer WW, Mastrangelo R, Stulberg CS, Poulik MD, Page RH, Thomp-son RI. Autoimmune hemolytic anemia. Natural history and viral-immunologic interactions in childhood. Am J Med 1970; 49: 80-93.
12. Nydegger UE, Kazatchkine MD, Miescher PA. Immunopathologic and clinical features of hemolytic anemia due to cold agglutinins. Semin Hematol 1991; 28: 66-77.
13. Bauduer F. Rituximab: a very efficient therapy in cold agglutinins and refractory autoimmune haemolytic anaemia associated with CD20-positive, low-grade non-Hodgkin's lymphoma. Br J Haematol 2001; 112: 1085-6.
14. Lee EJ, Kueck B. Rituxan in the treatment of cold agglutinin disease. Blood 1998; 92: 3490-1.
15. Göttsche B, Salama A, Mueller-Eckhardt C. Donath-Landsteiner autoimmune hemolytic anemia in children. A study of 22 cases. Vox Sang 1990; 58: 281-6.
16. Nordhagen R, Stensvold K, Winsnes A, Skyberg D, Storen A. Paroxysmal cold haemoglobinuria. The most frequent acute autoimmune haemolytic anaemia in children? Acta Paediatr Scand 1984; 73: 258-62.
17. Heddle NM. Acute paroxysmal cold hemoglobinuria. Transfus Med Rev 1989; 3: 219-29.
18. Worlledge S, Rousso C. Studies on the serology of paroxysmal cold haemoglobinuria (PCH) with special reference to its relationship with the P blood group system. Vox Sang 1965; 10: 293-8.
19. Lindgren S, Zimmerman S, Gibbs F, Garratty G. An unusual Donath-Landsteiner antibody detectable at 37 degrees C by the antiglobulin test. Transfusion 1985; 25: 142-4.
20. Nordhagen R. Two cases of paroxysmal cold hemoglobinuria with a Donath-Landsteiner antibody reactive by the indirect antiglobulin test using anti-IgG. Transfusion 1991; 31: 190-1.
21. Ries CA, Garratty G, Petz LD, Fudenberg HH. Paroxysmal cold hemoglobinuria: report of a case with an exceptionally high thermal range Donath-Landsteiner antibody. Blood 1971; 38: 491-9.
22. Issitt PD, Anstee DJ. Applied blood group serology. Durham, N.C. Montgomery Scientific Publications: 4.th ed. 1998.
23. Mollison PL, Engelfriet CP, Contreras M, Jones J. Blood transfusion in clinical medicine. Oxford Blackwell Science: 10th ed. 1997.
24. Bowman JM. Treatment Options for the Fetus With Alloimmune Hemolytic Disease. Transfus Med Rev 1990; IV/3: 191-207.
25. Ramsey G. Red Cell antibodies arising from solid organ transplants. Transfusion 1991; 31: 76-86.
26. Seltsam A, Hell A, Heymann G, Salama A. Donor-derived alloantibodies and passenger lymphocyte syndrome in two of four patients who received different organs from the same donor. Transfusion 2001; 41: 365-70.
27. Salama A, Mueller-Eckhardt C. Immune-mediated blood cell dyscarias related to drugs. Semin Hematol 1992; 29: 54-63.
28. Meyer O, Hackstein H, Hoppe B, Göbel FJ, Bein G, Salama A. Fatal immune haemolysis due to a degradation product of ceftriaxone. Br J Haematol 1999; 105: 1084-5.
29. Ware RE, Rosse WF, Howard TA. Mutations Within the Piga Gene in Patients With Paroxysmal Nocturnal Hemoglobinuria. Blood 1994; 83: 2418-22.
30. Ware RE, Hall SE, Rosse WF. Paroxysmal Nocturnal Hemoglobinuria With Onset in Childhood and Adolescence. N Engl J Med 1991; 325: 991-6.
31. Astori C, Bonfichi M, Pagnucco G, et al. Treatment with recombinant human erythropoietin (rHuEpo) in a patient with paroxysmal nocturnal haemoglobinuria: evaluation of membrane proteins CD55 and CD59 with cytofluorometric assay. Br J Haematol 1997; 97 (3): 586-8.